Ane L. Appelt
Institute Of Medical Research At St James's
Leeds, ENG, United Kingdom
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer - Endorsed by ASTRO.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 08, 2026
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered.
Journal: Clinical and translational radiation oncology
Published: May 27, 2026
Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 12, 2026
Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 12, 2026
In Reply to DeLaney.
Journal: International journal of radiation oncology, biology, physics
Published: February 08, 2026
ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 28, 2026
ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 28, 2026
NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 26, 2025
Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.
Journal: The Lancet. Oncology
Published: November 26, 2025
Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group.
Journal: Clinical and translational radiation oncology
Published: November 14, 2025
Robust organ mapped dose: using multiple image registrations to identify deformation uncertainty in radiation dose mapping.
Journal: Physics in medicine and biology
Published: November 04, 2025
Standardising image registration and dose mapping for thoracic reirradiation: A national multi-centre benchmarking study.
Journal: Physics and imaging in radiation oncology
Published: September 21, 2025
Last Updated: 09/26/2026